Average cost of drugs for extensively drug-resistant tuberculosis in Mongolia
Mongolia: Average cost of drugs for extensively drug-resistant tuberculosis was 1,900 constant 2022 US$ in 2024. ◆ Volatile
Average cost of drugs for extensively drug-resistant tuberculosis in Mongolia, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of drugs for extensively drug-resistant tuberculosis in Mongolia is 1,900 constant 2022 US$, measured in 2024.
Compared with earlier readings it is up 5.6% on the previous year and down 89.4% over ten years.
That places Mongolia 28th out of 56 countries with data for 2024, putting it in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Mongolia, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 18,000 constant 2022 US$ | — |
| 2018 | 18,000 constant 2022 US$ | +0.0% |
| 2019 | 8,000 constant 2022 US$ | -55.6% |
| 2020 | 3,300 constant 2022 US$ | -58.8% |
| 2021 | 1,800 constant 2022 US$ | -45.5% |
| 2022 | 1,800 constant 2022 US$ | +0.0% |
| 2023 | 1,800 constant 2022 US$ | +0.0% |
| 2024 | 1,900 constant 2022 US$ | +5.6% |
Mongolia compared with similar countries
- Mongolia's 1,900 constant 2022 US$ is below the median for upper middle income countries, which is 2,000 constant 2022 US$, 95% of the median. (23 countries reporting)
- Mongolia's 1,900 constant 2022 US$ is above the median for East Asia & Pacific, which is 1,194 constant 2022 US$, 1.6× the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 14,667 constant 2022 US$ | 8,000 constant 2022 US$ | 18,000 constant 2022 US$ | 3 |
| 2020s | 2,120 constant 2022 US$ | 1,800 constant 2022 US$ | 3,300 constant 2022 US$ | 5 |
Countries ranked near Mongolia
More reference data data for Mongolia
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.8173 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 3.37 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 4.25 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.0069 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 4.25 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 2.74 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 3.16 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 12.74 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 18.89 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.0378 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Mongolia?
- Average cost of drugs for extensively drug-resistant tuberculosis in Mongolia was 1,900 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Mongolia?
- The highest recorded value was 18,000 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Mongolia?
- The lowest recorded value was 1,800 constant 2022 US$ in 2021.
- How does Mongolia rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Mongolia ranks 28th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Mongolia?
- Over the last ten years it is down 89.4%. The long-run trend across the full record is volatile.
- Where does this Mongolia data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.